Presima Securities ULC Sells 287,061 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Presima Securities ULC trimmed its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 29.2% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 695,216 shares of the real estate investment trust’s stock after selling 287,061 shares during the quarter. Healthpeak Properties comprises approximately 3.5% of Presima Securities ULC’s portfolio, making the stock its 13th biggest position. Presima Securities ULC owned about 0.10% of Healthpeak Properties worth $14,092,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. HM Payson & Co. purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at about $25,000. S.A. Mason LLC purchased a new position in Healthpeak Properties during the third quarter valued at $26,000. Rise Advisors LLC bought a new stake in Healthpeak Properties during the third quarter valued at about $29,000. Fortitude Family Office LLC bought a new position in shares of Healthpeak Properties during the 3rd quarter valued at approximately $32,000. Finally, Barrett & Company Inc. purchased a new stake in Healthpeak Properties in the 3rd quarter worth approximately $33,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Analysts Set New Price Targets

DOC has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft upgraded shares of Healthpeak Properties from a “hold” rating to a “buy” rating and upped their price target for the stock from $20.00 to $28.00 in a research report on Monday, October 21st. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target on the stock in a report on Wednesday, January 15th. Robert W. Baird upped their price objective on Healthpeak Properties from $24.00 to $25.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Mizuho lowered their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Thursday, December 5th. Finally, Royal Bank of Canada increased their price objective on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Healthpeak Properties currently has a consensus rating of “Moderate Buy” and a consensus target price of $24.15.

Healthpeak Properties Trading Up 0.8 %

DOC opened at $20.82 on Friday. The stock has a 50-day moving average of $20.83 and a 200 day moving average of $21.53. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93. Healthpeak Properties, Inc. has a 12 month low of $16.01 and a 12 month high of $23.26. The firm has a market cap of $14.56 billion, a P/E ratio of 44.29, a P/E/G ratio of 2.21 and a beta of 1.14.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.32). The company had revenue of $700.40 million for the quarter, compared to the consensus estimate of $682.51 million. Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The business’s revenue for the quarter was up 25.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.45 EPS. As a group, research analysts forecast that Healthpeak Properties, Inc. will post 1.81 EPS for the current year.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.